Upcoming Events

Bethesda, MD

Virtual Event

Speakers:
David Novotny, Chief Operating Officer, Trial Services - RQM+
John Reites, CEO - THREAD

See MedTech study examples that utilize hybrid study approaches to accelerate patient recruitment.

Virtual Event

Speakers:
Ed Ball, CEng, MIPEM, MIMMM - Manager, Intelligence & Strategic Execution

Join us for an eye-opening 30-minute presentation and additional 15 minutes of Q&A, where RQM+ Manager of Intelligence and Strategic Execution, Ed Ball, MSc CEng MIPEM, will explore the vital role of communication throughout the risk management activities conducted over the course of the medical devices lifecycle. Drawing from his extensive experience in the industry, having worked for the UK’s MHRA and several device manufacturers, Ed will share insights and strategies to help you elevate your risk management processes.

Virtual Event

Speakers:
Mark DuVal – President & CEO, DuVal & Associates, P.A.
Allison Komiyama, Ph.D., RAC – Vice President, MedTech Innovations, RQM+
Jon Gimbel, Ph.D. – Vice President of Technical, RQM+
Erin Gontang – Senior Consultant, RQM+
Jaishankar (Jai) Kutty, Ph.D. – Vice President, Global Regulatory Affairs (moderator)

The FDA's recently proposed rule on wound care products has sent ripples through MedTech. This rule, if finalized, could significantly impact the classification, labeling, and testing requirements for a wide range of wound care devices. This online panel is your key to understanding the potential implications of this rule on your products and to prepare for the changes. In this conversation, our team of FDA regulatory experts will examine the proposed rule, providing valuable insights and actionable strategies to help you navigate what's next for wound care devices.